Several studies have demonstrated a link between serum concentrations of ESM1 and hypertension and cardiovascular disease (50), as well as renal damage (51), suggesting it may have clinical utility as an inflammatory biomarker (50–52). Here, ESM1 is linked to cardiovascular disorder.